| Udenafil |
| 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-n-(2-(1-methyl-2-pyrrolidinyl)ethyl)-4-propoxybenzenesulfonamide |
| (CAS 268203-93-6) |
 |
| Description： |
Udenafil(DA8159) is a PDE5 inhibitor used in urology to treat erectile dysfunction.
Target: PDE5
Udenafil is an oral PDE5 inhibitor. Udenafil significantly increased cAMP and cGMP levels and were more highly distributed in the prostate than plasma. The T/P ratio of udenafil was higher than tadalafil. These findings may help in the assessment of the feasibility of using PDE5 Is to concurrently treat both LUTS and erectile dysfunction. After 12 weeks of treatment, the patients treated with udenafil showed significantly greater change from baseline in the IIEF-EF domain score compared with placebo (placebo, 0.20; 100-mg udenafil, 7.52; and 200-mg udenafil, 9.93, respectively) (P < 0.0001). udenafil significantly enhanced the rates of successful penetration (SEP Q2) and maintenance of erection (SEP Q3) (P < 0.0001).
|
| Product No. |
KT20484 |
| Product Name |
Udenafil |
| Synonyms |
DA8159; Zydena |
| Formal Name |
3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo(4,3-d)pyrimidin-5-yl)-n-(2-(1-methyl-2-pyrrolidinyl)ethyl)-4-propoxybenzenesulfonamide |
| CAS Number |
268203-93-6 |
| Molecular Formula |
C25H36N6O4S |
| Formula Weight |
516.66 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
PDE
Pentoxifylline
PF-04447943
PF-2545920
Pimobendan
Roflumilast
Rolipram
Sildenafil
Vardenafil
Vinpocetine
Zardaverine
|
|
